Global PRRS Vaccines Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PRRS Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation?such as the development of region-specific or genotype-specific modified live vaccines (MLVs)?have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.
The global PRRS Vaccines market size was estimated at USD 410.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global PRRS Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global PRRS Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PRRS Vaccines market.
Global PRRS Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
China Animal Husbandry Co., Ltd.
Boehringer Ingelheim
MSD Animal Health
Sinopharm Animal Health
Ceva
Ruipu Biological
Qilu Animal Health
Dahuanong
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu
Phibro Animal Health
Tiankang
Zoetis
Yongshun Biological
Pulike Biological
Market Segmentation (by Type)
Live Vaccines
Killed Vaccines
Market Segmentation (by Application)
Government Tender
Market Sales
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PRRS Vaccines Market
Overview of the regional outlook of the PRRS Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PRRS Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PRRS Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global PRRS Vaccines market size was estimated at USD 410.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global PRRS Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global PRRS Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the PRRS Vaccines market.
Global PRRS Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
China Animal Husbandry Co., Ltd.
Boehringer Ingelheim
MSD Animal Health
Sinopharm Animal Health
Ceva
Ruipu Biological
Qilu Animal Health
Dahuanong
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu
Phibro Animal Health
Tiankang
Zoetis
Yongshun Biological
Pulike Biological
Market Segmentation (by Type)
Live Vaccines
Killed Vaccines
Market Segmentation (by Application)
Government Tender
Market Sales
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PRRS Vaccines Market
Overview of the regional outlook of the PRRS Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PRRS Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of PRRS Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PRRS Vaccines
1.2 Key Market Segments
1.2.1 PRRS Vaccines Segment by Type
1.2.2 PRRS Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRRS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PRRS Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global PRRS Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRRS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global PRRS Vaccines Product Life Cycle
3.3 Global PRRS Vaccines Sales by Manufacturers (2020-2025)
3.4 Global PRRS Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PRRS Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PRRS Vaccines Market Competitive Situation and Trends
3.8.1 PRRS Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRRS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 PRRS Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRRS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global PRRS Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to PRRS Vaccines Market
5.7 ESG Ratings of Leading Companies
6 PRRS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PRRS Vaccines Sales Market Share by Type (2020-2025)
6.3 Global PRRS Vaccines Market Size by Type (2020-2025)
6.4 Global PRRS Vaccines Price by Type (2020-2025)
7 PRRS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PRRS Vaccines Market Sales by Application (2020-2025)
7.3 Global PRRS Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
8 PRRS VACCINES MARKET SALES BY REGION
8.1 Global PRRS Vaccines Sales by Region
8.1.1 Global PRRS Vaccines Sales by Region
8.1.2 Global PRRS Vaccines Sales Market Share by Region
8.2 Global PRRS Vaccines Market Size by Region
8.2.1 Global PRRS Vaccines Market Size by Region
8.2.2 Global PRRS Vaccines Market Size by Region
8.3 North America
8.3.1 North America PRRS Vaccines Sales by Country
8.3.2 North America PRRS Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe PRRS Vaccines Sales by Country
8.4.2 Europe PRRS Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific PRRS Vaccines Sales by Region
8.5.2 Asia Pacific PRRS Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America PRRS Vaccines Sales by Country
8.6.2 South America PRRS Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa PRRS Vaccines Sales by Region
8.7.2 Middle East and Africa PRRS Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRRS VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of PRRS Vaccines by Region(2020-2025)
9.2 Global PRRS Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PRRS Vaccines Production
9.4.1 North America PRRS Vaccines Production Growth Rate (2020-2025)
9.4.2 North America PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PRRS Vaccines Production
9.5.1 Europe PRRS Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PRRS Vaccines Production (2020-2025)
9.6.1 Japan PRRS Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PRRS Vaccines Production (2020-2025)
9.7.1 China PRRS Vaccines Production Growth Rate (2020-2025)
9.7.2 China PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 China Animal Husbandry Co., Ltd.
10.1.1 China Animal Husbandry Co., Ltd. Basic Information
10.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Overview
10.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Market Performance
10.1.4 China Animal Husbandry Co., Ltd. Business Overview
10.1.5 China Animal Husbandry Co., Ltd. SWOT Analysis
10.1.6 China Animal Husbandry Co., Ltd. Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim PRRS Vaccines Product Overview
10.2.3 Boehringer Ingelheim PRRS Vaccines Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 MSD Animal Health
10.3.1 MSD Animal Health Basic Information
10.3.2 MSD Animal Health PRRS Vaccines Product Overview
10.3.3 MSD Animal Health PRRS Vaccines Product Market Performance
10.3.4 MSD Animal Health Business Overview
10.3.5 MSD Animal Health SWOT Analysis
10.3.6 MSD Animal Health Recent Developments
10.4 Sinopharm Animal Health
10.4.1 Sinopharm Animal Health Basic Information
10.4.2 Sinopharm Animal Health PRRS Vaccines Product Overview
10.4.3 Sinopharm Animal Health PRRS Vaccines Product Market Performance
10.4.4 Sinopharm Animal Health Business Overview
10.4.5 Sinopharm Animal Health Recent Developments
10.5 Ceva
10.5.1 Ceva Basic Information
10.5.2 Ceva PRRS Vaccines Product Overview
10.5.3 Ceva PRRS Vaccines Product Market Performance
10.5.4 Ceva Business Overview
10.5.5 Ceva Recent Developments
10.6 Ruipu Biological
10.6.1 Ruipu Biological Basic Information
10.6.2 Ruipu Biological PRRS Vaccines Product Overview
10.6.3 Ruipu Biological PRRS Vaccines Product Market Performance
10.6.4 Ruipu Biological Business Overview
10.6.5 Ruipu Biological Recent Developments
10.7 Qilu Animal Health
10.7.1 Qilu Animal Health Basic Information
10.7.2 Qilu Animal Health PRRS Vaccines Product Overview
10.7.3 Qilu Animal Health PRRS Vaccines Product Market Performance
10.7.4 Qilu Animal Health Business Overview
10.7.5 Qilu Animal Health Recent Developments
10.8 Dahuanong
10.8.1 Dahuanong Basic Information
10.8.2 Dahuanong PRRS Vaccines Product Overview
10.8.3 Dahuanong PRRS Vaccines Product Market Performance
10.8.4 Dahuanong Business Overview
10.8.5 Dahuanong Recent Developments
10.9 CAVAC
10.9.1 CAVAC Basic Information
10.9.2 CAVAC PRRS Vaccines Product Overview
10.9.3 CAVAC PRRS Vaccines Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Komipharm
10.10.1 Komipharm Basic Information
10.10.2 Komipharm PRRS Vaccines Product Overview
10.10.3 Komipharm PRRS Vaccines Product Market Performance
10.10.4 Komipharm Business Overview
10.10.5 Komipharm Recent Developments
10.11 Agrovet
10.11.1 Agrovet Basic Information
10.11.2 Agrovet PRRS Vaccines Product Overview
10.11.3 Agrovet PRRS Vaccines Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Bioveta
10.12.1 Bioveta Basic Information
10.12.2 Bioveta PRRS Vaccines Product Overview
10.12.3 Bioveta PRRS Vaccines Product Market Performance
10.12.4 Bioveta Business Overview
10.12.5 Bioveta Recent Developments
10.13 Jinyu
10.13.1 Jinyu Basic Information
10.13.2 Jinyu PRRS Vaccines Product Overview
10.13.3 Jinyu PRRS Vaccines Product Market Performance
10.13.4 Jinyu Business Overview
10.13.5 Jinyu Recent Developments
10.14 Phibro Animal Health
10.14.1 Phibro Animal Health Basic Information
10.14.2 Phibro Animal Health PRRS Vaccines Product Overview
10.14.3 Phibro Animal Health PRRS Vaccines Product Market Performance
10.14.4 Phibro Animal Health Business Overview
10.14.5 Phibro Animal Health Recent Developments
10.15 Tiankang
10.15.1 Tiankang Basic Information
10.15.2 Tiankang PRRS Vaccines Product Overview
10.15.3 Tiankang PRRS Vaccines Product Market Performance
10.15.4 Tiankang Business Overview
10.15.5 Tiankang Recent Developments
10.16 Zoetis
10.16.1 Zoetis Basic Information
10.16.2 Zoetis PRRS Vaccines Product Overview
10.16.3 Zoetis PRRS Vaccines Product Market Performance
10.16.4 Zoetis Business Overview
10.16.5 Zoetis Recent Developments
10.17 Yongshun Biological
10.17.1 Yongshun Biological Basic Information
10.17.2 Yongshun Biological PRRS Vaccines Product Overview
10.17.3 Yongshun Biological PRRS Vaccines Product Market Performance
10.17.4 Yongshun Biological Business Overview
10.17.5 Yongshun Biological Recent Developments
10.18 Pulike Biological
10.18.1 Pulike Biological Basic Information
10.18.2 Pulike Biological PRRS Vaccines Product Overview
10.18.3 Pulike Biological PRRS Vaccines Product Market Performance
10.18.4 Pulike Biological Business Overview
10.18.5 Pulike Biological Recent Developments
11 PRRS VACCINES MARKET FORECAST BY REGION
11.1 Global PRRS Vaccines Market Size Forecast
11.2 Global PRRS Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PRRS Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific PRRS Vaccines Market Size Forecast by Region
11.2.4 South America PRRS Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of PRRS Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global PRRS Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of PRRS Vaccines by Type (2026-2035)
12.1.2 Global PRRS Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of PRRS Vaccines by Type (2026-2035)
12.2 Global PRRS Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global PRRS Vaccines Sales (K Units) Forecast by Application
12.2.2 Global PRRS Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PRRS Vaccines
1.2 Key Market Segments
1.2.1 PRRS Vaccines Segment by Type
1.2.2 PRRS Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRRS VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PRRS Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global PRRS Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRRS VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global PRRS Vaccines Product Life Cycle
3.3 Global PRRS Vaccines Sales by Manufacturers (2020-2025)
3.4 Global PRRS Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global PRRS Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 PRRS Vaccines Market Competitive Situation and Trends
3.8.1 PRRS Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRRS VACCINES INDUSTRY CHAIN ANALYSIS
4.1 PRRS Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRRS VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global PRRS Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to PRRS Vaccines Market
5.7 ESG Ratings of Leading Companies
6 PRRS VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PRRS Vaccines Sales Market Share by Type (2020-2025)
6.3 Global PRRS Vaccines Market Size by Type (2020-2025)
6.4 Global PRRS Vaccines Price by Type (2020-2025)
7 PRRS VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PRRS Vaccines Market Sales by Application (2020-2025)
7.3 Global PRRS Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
8 PRRS VACCINES MARKET SALES BY REGION
8.1 Global PRRS Vaccines Sales by Region
8.1.1 Global PRRS Vaccines Sales by Region
8.1.2 Global PRRS Vaccines Sales Market Share by Region
8.2 Global PRRS Vaccines Market Size by Region
8.2.1 Global PRRS Vaccines Market Size by Region
8.2.2 Global PRRS Vaccines Market Size by Region
8.3 North America
8.3.1 North America PRRS Vaccines Sales by Country
8.3.2 North America PRRS Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe PRRS Vaccines Sales by Country
8.4.2 Europe PRRS Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific PRRS Vaccines Sales by Region
8.5.2 Asia Pacific PRRS Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America PRRS Vaccines Sales by Country
8.6.2 South America PRRS Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa PRRS Vaccines Sales by Region
8.7.2 Middle East and Africa PRRS Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRRS VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of PRRS Vaccines by Region(2020-2025)
9.2 Global PRRS Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America PRRS Vaccines Production
9.4.1 North America PRRS Vaccines Production Growth Rate (2020-2025)
9.4.2 North America PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe PRRS Vaccines Production
9.5.1 Europe PRRS Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan PRRS Vaccines Production (2020-2025)
9.6.1 Japan PRRS Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China PRRS Vaccines Production (2020-2025)
9.7.1 China PRRS Vaccines Production Growth Rate (2020-2025)
9.7.2 China PRRS Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 China Animal Husbandry Co., Ltd.
10.1.1 China Animal Husbandry Co., Ltd. Basic Information
10.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Overview
10.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Market Performance
10.1.4 China Animal Husbandry Co., Ltd. Business Overview
10.1.5 China Animal Husbandry Co., Ltd. SWOT Analysis
10.1.6 China Animal Husbandry Co., Ltd. Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim PRRS Vaccines Product Overview
10.2.3 Boehringer Ingelheim PRRS Vaccines Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 MSD Animal Health
10.3.1 MSD Animal Health Basic Information
10.3.2 MSD Animal Health PRRS Vaccines Product Overview
10.3.3 MSD Animal Health PRRS Vaccines Product Market Performance
10.3.4 MSD Animal Health Business Overview
10.3.5 MSD Animal Health SWOT Analysis
10.3.6 MSD Animal Health Recent Developments
10.4 Sinopharm Animal Health
10.4.1 Sinopharm Animal Health Basic Information
10.4.2 Sinopharm Animal Health PRRS Vaccines Product Overview
10.4.3 Sinopharm Animal Health PRRS Vaccines Product Market Performance
10.4.4 Sinopharm Animal Health Business Overview
10.4.5 Sinopharm Animal Health Recent Developments
10.5 Ceva
10.5.1 Ceva Basic Information
10.5.2 Ceva PRRS Vaccines Product Overview
10.5.3 Ceva PRRS Vaccines Product Market Performance
10.5.4 Ceva Business Overview
10.5.5 Ceva Recent Developments
10.6 Ruipu Biological
10.6.1 Ruipu Biological Basic Information
10.6.2 Ruipu Biological PRRS Vaccines Product Overview
10.6.3 Ruipu Biological PRRS Vaccines Product Market Performance
10.6.4 Ruipu Biological Business Overview
10.6.5 Ruipu Biological Recent Developments
10.7 Qilu Animal Health
10.7.1 Qilu Animal Health Basic Information
10.7.2 Qilu Animal Health PRRS Vaccines Product Overview
10.7.3 Qilu Animal Health PRRS Vaccines Product Market Performance
10.7.4 Qilu Animal Health Business Overview
10.7.5 Qilu Animal Health Recent Developments
10.8 Dahuanong
10.8.1 Dahuanong Basic Information
10.8.2 Dahuanong PRRS Vaccines Product Overview
10.8.3 Dahuanong PRRS Vaccines Product Market Performance
10.8.4 Dahuanong Business Overview
10.8.5 Dahuanong Recent Developments
10.9 CAVAC
10.9.1 CAVAC Basic Information
10.9.2 CAVAC PRRS Vaccines Product Overview
10.9.3 CAVAC PRRS Vaccines Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Komipharm
10.10.1 Komipharm Basic Information
10.10.2 Komipharm PRRS Vaccines Product Overview
10.10.3 Komipharm PRRS Vaccines Product Market Performance
10.10.4 Komipharm Business Overview
10.10.5 Komipharm Recent Developments
10.11 Agrovet
10.11.1 Agrovet Basic Information
10.11.2 Agrovet PRRS Vaccines Product Overview
10.11.3 Agrovet PRRS Vaccines Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Bioveta
10.12.1 Bioveta Basic Information
10.12.2 Bioveta PRRS Vaccines Product Overview
10.12.3 Bioveta PRRS Vaccines Product Market Performance
10.12.4 Bioveta Business Overview
10.12.5 Bioveta Recent Developments
10.13 Jinyu
10.13.1 Jinyu Basic Information
10.13.2 Jinyu PRRS Vaccines Product Overview
10.13.3 Jinyu PRRS Vaccines Product Market Performance
10.13.4 Jinyu Business Overview
10.13.5 Jinyu Recent Developments
10.14 Phibro Animal Health
10.14.1 Phibro Animal Health Basic Information
10.14.2 Phibro Animal Health PRRS Vaccines Product Overview
10.14.3 Phibro Animal Health PRRS Vaccines Product Market Performance
10.14.4 Phibro Animal Health Business Overview
10.14.5 Phibro Animal Health Recent Developments
10.15 Tiankang
10.15.1 Tiankang Basic Information
10.15.2 Tiankang PRRS Vaccines Product Overview
10.15.3 Tiankang PRRS Vaccines Product Market Performance
10.15.4 Tiankang Business Overview
10.15.5 Tiankang Recent Developments
10.16 Zoetis
10.16.1 Zoetis Basic Information
10.16.2 Zoetis PRRS Vaccines Product Overview
10.16.3 Zoetis PRRS Vaccines Product Market Performance
10.16.4 Zoetis Business Overview
10.16.5 Zoetis Recent Developments
10.17 Yongshun Biological
10.17.1 Yongshun Biological Basic Information
10.17.2 Yongshun Biological PRRS Vaccines Product Overview
10.17.3 Yongshun Biological PRRS Vaccines Product Market Performance
10.17.4 Yongshun Biological Business Overview
10.17.5 Yongshun Biological Recent Developments
10.18 Pulike Biological
10.18.1 Pulike Biological Basic Information
10.18.2 Pulike Biological PRRS Vaccines Product Overview
10.18.3 Pulike Biological PRRS Vaccines Product Market Performance
10.18.4 Pulike Biological Business Overview
10.18.5 Pulike Biological Recent Developments
11 PRRS VACCINES MARKET FORECAST BY REGION
11.1 Global PRRS Vaccines Market Size Forecast
11.2 Global PRRS Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PRRS Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific PRRS Vaccines Market Size Forecast by Region
11.2.4 South America PRRS Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of PRRS Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global PRRS Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of PRRS Vaccines by Type (2026-2035)
12.1.2 Global PRRS Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of PRRS Vaccines by Type (2026-2035)
12.2 Global PRRS Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global PRRS Vaccines Sales (K Units) Forecast by Application
12.2.2 Global PRRS Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PRRS Vaccines Market Size by Type (M USD)
Table 4. Global PRRS Vaccines Market Size by Application
Table 5. PRRS Vaccines Market Size Comparison by Region (M USD)
Table 6. Global PRRS Vaccines Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global PRRS Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PRRS Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PRRS Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2025)
Table 11. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PRRS Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PRRS Vaccines Sales by Type (K Units)
Table 27. Global PRRS Vaccines Market Size by Type (M USD)
Table 28. Global PRRS Vaccines Sales (K Units) by Type (2020-2025)
Table 29. Global PRRS Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global PRRS Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global PRRS Vaccines Market Share by Type (2020-2025)
Table 32. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2025)
Table 33. Global PRRS Vaccines Sales (K Units) by Application
Table 34. Global PRRS Vaccines Market Size by Application
Table 35. Global PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 36. Global PRRS Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global PRRS Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global PRRS Vaccines Market Share by Application (2020-2025)
Table 39. Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. Global PRRS Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global PRRS Vaccines Market Size by Region (2020-2025)
Table 44. North America PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. North America PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. South America PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global PRRS Vaccines Production (K Units) by Region(2020-2025)
Table 55. Global PRRS Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PRRS Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. China Animal Husbandry Co., Ltd. Basic Information
Table 63. China Animal Husbandry Co., Ltd. PRRS Vaccines Product Overview
Table 64. China Animal Husbandry Co., Ltd. PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. China Animal Husbandry Co., Ltd. Business Overview
Table 66. China Animal Husbandry Co., Ltd. SWOT Analysis
Table 67. China Animal Husbandry Co., Ltd. Recent Developments
Table 68. Boehringer Ingelheim Basic Information
Table 69. Boehringer Ingelheim PRRS Vaccines Product Overview
Table 70. Boehringer Ingelheim PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. MSD Animal Health Basic Information
Table 75. MSD Animal Health PRRS Vaccines Product Overview
Table 76. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. MSD Animal Health Business Overview
Table 78. MSD Animal Health SWOT Analysis
Table 79. MSD Animal Health Recent Developments
Table 80. Sinopharm Animal Health Basic Information
Table 81. Sinopharm Animal Health PRRS Vaccines Product Overview
Table 82. Sinopharm Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sinopharm Animal Health Business Overview
Table 84. Sinopharm Animal Health Recent Developments
Table 85. Ceva Basic Information
Table 86. Ceva PRRS Vaccines Product Overview
Table 87. Ceva PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Ceva Business Overview
Table 89. Ceva Recent Developments
Table 90. Ruipu Biological Basic Information
Table 91. Ruipu Biological PRRS Vaccines Product Overview
Table 92. Ruipu Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ruipu Biological Business Overview
Table 94. Ruipu Biological Recent Developments
Table 95. Qilu Animal Health Basic Information
Table 96. Qilu Animal Health PRRS Vaccines Product Overview
Table 97. Qilu Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Qilu Animal Health Business Overview
Table 99. Qilu Animal Health Recent Developments
Table 100. Dahuanong Basic Information
Table 101. Dahuanong PRRS Vaccines Product Overview
Table 102. Dahuanong PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Dahuanong Business Overview
Table 104. Dahuanong Recent Developments
Table 105. CAVAC Basic Information
Table 106. CAVAC PRRS Vaccines Product Overview
Table 107. CAVAC PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. CAVAC Business Overview
Table 109. CAVAC Recent Developments
Table 110. Komipharm Basic Information
Table 111. Komipharm PRRS Vaccines Product Overview
Table 112. Komipharm PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Komipharm Business Overview
Table 114. Komipharm Recent Developments
Table 115. Agrovet Basic Information
Table 116. Agrovet PRRS Vaccines Product Overview
Table 117. Agrovet PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Agrovet Business Overview
Table 119. Agrovet Recent Developments
Table 120. Bioveta Basic Information
Table 121. Bioveta PRRS Vaccines Product Overview
Table 122. Bioveta PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Bioveta Business Overview
Table 124. Bioveta Recent Developments
Table 125. Jinyu Basic Information
Table 126. Jinyu PRRS Vaccines Product Overview
Table 127. Jinyu PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Jinyu Business Overview
Table 129. Jinyu Recent Developments
Table 130. Phibro Animal Health Basic Information
Table 131. Phibro Animal Health PRRS Vaccines Product Overview
Table 132. Phibro Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Phibro Animal Health Business Overview
Table 134. Phibro Animal Health Recent Developments
Table 135. Tiankang Basic Information
Table 136. Tiankang PRRS Vaccines Product Overview
Table 137. Tiankang PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Tiankang Business Overview
Table 139. Tiankang Recent Developments
Table 140. Zoetis Basic Information
Table 141. Zoetis PRRS Vaccines Product Overview
Table 142. Zoetis PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Zoetis Business Overview
Table 144. Zoetis Recent Developments
Table 145. Yongshun Biological Basic Information
Table 146. Yongshun Biological PRRS Vaccines Product Overview
Table 147. Yongshun Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Yongshun Biological Business Overview
Table 149. Yongshun Biological Recent Developments
Table 150. Pulike Biological Basic Information
Table 151. Pulike Biological PRRS Vaccines Product Overview
Table 152. Pulike Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Pulike Biological Business Overview
Table 154. Pulike Biological Recent Developments
Table 155. Global PRRS Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 156. Global PRRS Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 158. North America PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 160. Europe PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific PRRS Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 162. Asia Pacific PRRS Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 164. South America PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa PRRS Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global PRRS Vaccines Sales Forecast by Type (2026-2035) & (K Units)
Table 168. Global PRRS Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global PRRS Vaccines Price Forecast by Type (2026-2035) & (USD/Unit)
Table 170. Global PRRS Vaccines Sales (K Units) Forecast by Application (2026-2035)
Table 171. Global PRRS Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global PRRS Vaccines Market Size by Type (M USD)
Table 4. Global PRRS Vaccines Market Size by Application
Table 5. PRRS Vaccines Market Size Comparison by Region (M USD)
Table 6. Global PRRS Vaccines Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global PRRS Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global PRRS Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global PRRS Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2025)
Table 11. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PRRS Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global PRRS Vaccines Sales by Type (K Units)
Table 27. Global PRRS Vaccines Market Size by Type (M USD)
Table 28. Global PRRS Vaccines Sales (K Units) by Type (2020-2025)
Table 29. Global PRRS Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global PRRS Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global PRRS Vaccines Market Share by Type (2020-2025)
Table 32. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2025)
Table 33. Global PRRS Vaccines Sales (K Units) by Application
Table 34. Global PRRS Vaccines Market Size by Application
Table 35. Global PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 36. Global PRRS Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global PRRS Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global PRRS Vaccines Market Share by Application (2020-2025)
Table 39. Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. Global PRRS Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global PRRS Vaccines Market Size by Region (2020-2025)
Table 44. North America PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. North America PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Europe PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 51. South America PRRS Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa PRRS Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global PRRS Vaccines Production (K Units) by Region(2020-2025)
Table 55. Global PRRS Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global PRRS Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China PRRS Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. China Animal Husbandry Co., Ltd. Basic Information
Table 63. China Animal Husbandry Co., Ltd. PRRS Vaccines Product Overview
Table 64. China Animal Husbandry Co., Ltd. PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. China Animal Husbandry Co., Ltd. Business Overview
Table 66. China Animal Husbandry Co., Ltd. SWOT Analysis
Table 67. China Animal Husbandry Co., Ltd. Recent Developments
Table 68. Boehringer Ingelheim Basic Information
Table 69. Boehringer Ingelheim PRRS Vaccines Product Overview
Table 70. Boehringer Ingelheim PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. MSD Animal Health Basic Information
Table 75. MSD Animal Health PRRS Vaccines Product Overview
Table 76. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. MSD Animal Health Business Overview
Table 78. MSD Animal Health SWOT Analysis
Table 79. MSD Animal Health Recent Developments
Table 80. Sinopharm Animal Health Basic Information
Table 81. Sinopharm Animal Health PRRS Vaccines Product Overview
Table 82. Sinopharm Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sinopharm Animal Health Business Overview
Table 84. Sinopharm Animal Health Recent Developments
Table 85. Ceva Basic Information
Table 86. Ceva PRRS Vaccines Product Overview
Table 87. Ceva PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Ceva Business Overview
Table 89. Ceva Recent Developments
Table 90. Ruipu Biological Basic Information
Table 91. Ruipu Biological PRRS Vaccines Product Overview
Table 92. Ruipu Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ruipu Biological Business Overview
Table 94. Ruipu Biological Recent Developments
Table 95. Qilu Animal Health Basic Information
Table 96. Qilu Animal Health PRRS Vaccines Product Overview
Table 97. Qilu Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Qilu Animal Health Business Overview
Table 99. Qilu Animal Health Recent Developments
Table 100. Dahuanong Basic Information
Table 101. Dahuanong PRRS Vaccines Product Overview
Table 102. Dahuanong PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Dahuanong Business Overview
Table 104. Dahuanong Recent Developments
Table 105. CAVAC Basic Information
Table 106. CAVAC PRRS Vaccines Product Overview
Table 107. CAVAC PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. CAVAC Business Overview
Table 109. CAVAC Recent Developments
Table 110. Komipharm Basic Information
Table 111. Komipharm PRRS Vaccines Product Overview
Table 112. Komipharm PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Komipharm Business Overview
Table 114. Komipharm Recent Developments
Table 115. Agrovet Basic Information
Table 116. Agrovet PRRS Vaccines Product Overview
Table 117. Agrovet PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Agrovet Business Overview
Table 119. Agrovet Recent Developments
Table 120. Bioveta Basic Information
Table 121. Bioveta PRRS Vaccines Product Overview
Table 122. Bioveta PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Bioveta Business Overview
Table 124. Bioveta Recent Developments
Table 125. Jinyu Basic Information
Table 126. Jinyu PRRS Vaccines Product Overview
Table 127. Jinyu PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Jinyu Business Overview
Table 129. Jinyu Recent Developments
Table 130. Phibro Animal Health Basic Information
Table 131. Phibro Animal Health PRRS Vaccines Product Overview
Table 132. Phibro Animal Health PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Phibro Animal Health Business Overview
Table 134. Phibro Animal Health Recent Developments
Table 135. Tiankang Basic Information
Table 136. Tiankang PRRS Vaccines Product Overview
Table 137. Tiankang PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Tiankang Business Overview
Table 139. Tiankang Recent Developments
Table 140. Zoetis Basic Information
Table 141. Zoetis PRRS Vaccines Product Overview
Table 142. Zoetis PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Zoetis Business Overview
Table 144. Zoetis Recent Developments
Table 145. Yongshun Biological Basic Information
Table 146. Yongshun Biological PRRS Vaccines Product Overview
Table 147. Yongshun Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Yongshun Biological Business Overview
Table 149. Yongshun Biological Recent Developments
Table 150. Pulike Biological Basic Information
Table 151. Pulike Biological PRRS Vaccines Product Overview
Table 152. Pulike Biological PRRS Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Pulike Biological Business Overview
Table 154. Pulike Biological Recent Developments
Table 155. Global PRRS Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 156. Global PRRS Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 158. North America PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 160. Europe PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific PRRS Vaccines Sales Forecast by Region (2026-2035) & (K Units)
Table 162. Asia Pacific PRRS Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America PRRS Vaccines Sales Forecast by Country (2026-2035) & (K Units)
Table 164. South America PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa PRRS Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa PRRS Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global PRRS Vaccines Sales Forecast by Type (2026-2035) & (K Units)
Table 168. Global PRRS Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global PRRS Vaccines Price Forecast by Type (2026-2035) & (USD/Unit)
Table 170. Global PRRS Vaccines Sales (K Units) Forecast by Application (2026-2035)
Table 171. Global PRRS Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PRRS Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PRRS Vaccines Market Size (M USD), 2025-2035
Figure 5. Global PRRS Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global PRRS Vaccines Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PRRS Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PRRS Vaccines Product Life Cycle
Figure 13. PRRS Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global PRRS Vaccines Revenue Share by Manufacturers in 2025
Figure 15. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2025
Figure 18. Industry Chain Map of PRRS Vaccines
Figure 19. Global PRRS Vaccines Market PEST Analysis
Figure 20. Global PRRS Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PRRS Vaccines Market Share by Type
Figure 27. Sales Market Share of PRRS Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of PRRS Vaccines by Type in 2025
Figure 29. Market Share of PRRS Vaccines by Type (2020-2025)
Figure 30. Market Share of PRRS Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PRRS Vaccines Market Share by Application
Figure 33. Global PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global PRRS Vaccines Sales Market Share by Application in 2025
Figure 35. Global PRRS Vaccines Market Share by Application (2020-2025)
Figure 36. Global PRRS Vaccines Market Share by Application in 2025
Figure 37. Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global PRRS Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global PRRS Vaccines Market Size by Region (2020-2025)
Figure 40. North America PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America PRRS Vaccines Sales Market Share by Country in 2024
Figure 43. North America PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PRRS Vaccines Market Size by Country in 2024
Figure 45. U.S. PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PRRS Vaccines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada PRRS Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PRRS Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PRRS Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe PRRS Vaccines Sales Market Share by Country in 2024
Figure 53. Europe PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PRRS Vaccines Market Size by Country in 2024
Figure 55. Germany PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PRRS Vaccines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific PRRS Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific PRRS Vaccines Market Size by Region in 2024
Figure 68. China PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PRRS Vaccines Sales and Growth Rate (K Units)
Figure 79. South America PRRS Vaccines Sales Market Share by Country in 2024
Figure 80. South America PRRS Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America PRRS Vaccines Market Size by Country in 2024
Figure 82. Brazil PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PRRS Vaccines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa PRRS Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PRRS Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PRRS Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PRRS Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 106. China PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global PRRS Vaccines Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global PRRS Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PRRS Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PRRS Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global PRRS Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global PRRS Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of PRRS Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PRRS Vaccines Market Size (M USD), 2025-2035
Figure 5. Global PRRS Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global PRRS Vaccines Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PRRS Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global PRRS Vaccines Product Life Cycle
Figure 13. PRRS Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global PRRS Vaccines Revenue Share by Manufacturers in 2025
Figure 15. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market PRRS Vaccines Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2025
Figure 18. Industry Chain Map of PRRS Vaccines
Figure 19. Global PRRS Vaccines Market PEST Analysis
Figure 20. Global PRRS Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global PRRS Vaccines Market Share by Type
Figure 27. Sales Market Share of PRRS Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of PRRS Vaccines by Type in 2025
Figure 29. Market Share of PRRS Vaccines by Type (2020-2025)
Figure 30. Market Share of PRRS Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global PRRS Vaccines Market Share by Application
Figure 33. Global PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global PRRS Vaccines Sales Market Share by Application in 2025
Figure 35. Global PRRS Vaccines Market Share by Application (2020-2025)
Figure 36. Global PRRS Vaccines Market Share by Application in 2025
Figure 37. Global PRRS Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global PRRS Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global PRRS Vaccines Market Size by Region (2020-2025)
Figure 40. North America PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America PRRS Vaccines Sales Market Share by Country in 2024
Figure 43. North America PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America PRRS Vaccines Market Size by Country in 2024
Figure 45. U.S. PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada PRRS Vaccines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada PRRS Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico PRRS Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico PRRS Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe PRRS Vaccines Sales Market Share by Country in 2024
Figure 53. Europe PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe PRRS Vaccines Market Size by Country in 2024
Figure 55. Germany PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific PRRS Vaccines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific PRRS Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific PRRS Vaccines Market Size by Region in 2024
Figure 68. China PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America PRRS Vaccines Sales and Growth Rate (K Units)
Figure 79. South America PRRS Vaccines Sales Market Share by Country in 2024
Figure 80. South America PRRS Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America PRRS Vaccines Market Size by Country in 2024
Figure 82. Brazil PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa PRRS Vaccines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa PRRS Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa PRRS Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa PRRS Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa PRRS Vaccines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa PRRS Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global PRRS Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 106. China PRRS Vaccines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global PRRS Vaccines Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global PRRS Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global PRRS Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global PRRS Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global PRRS Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global PRRS Vaccines Market Share Forecast by Application (2026-2035)
